Skip to content
healthcare.dev

Neostigmine

NDC 43598-529, Neostigmine, injection, from Dr.Reddy's Laboratories Inc.

Product NDC
43598-529
Status
Listed
Labeler
Dr.Reddy's Laboratories Inc
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209135
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43598-529 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
43598-529-11435980529111 VIAL, MULTI-DOSE in 1 CARTON (43598-529-11) / 10 mL in 1 VIAL, MULTI-DOSE
43598-529-364359805293610 VIAL, MULTI-DOSE in 1 CARTON (43598-529-36) / 10 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/81243f47-bd25-bd02-518a-087badcca755

Use it

Look up 43598-529 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43598-529 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43598-529. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.